Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

517.33
Delayed Data
As of Jun 23
 -9.20 / -1.75%
Today’s Change
325.35
Today|||52-Week Range
543.55
+40.93%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues1.2B1.2B1.2B1.3B
 
 
 
 
 
Cost of Goods Sold69.0M44.2M74.7M84.2M
 
 
 
 
 
Depreciation And Amortization25.0M27.8M28.9M38.1M
 
 
 
 
 
 
Operating ExpensesGross Income1.1B1.1B1.1B1.2B
 
 
 
 
 
General Expenses826.9M785.3M776.2M766.2M
 
 
 
 
 
Research And Development534.9M515.2M450.3M469.3M
 
 
 
 
 
Total Operating Expenses921.0M857.3M879.8M888.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income291.6M362.8M347.0M430.5M
 
 
 
 
 
Interest Expense On Debt2.2M222.0K--7.5M
 
 
 
 
Other Expenses0.000.00-5.5M9.2M
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income292.3M365.9M341.5M432.3M
 
 
 
 
 
Income Taxes-96.0M-101.1M-88.4M-183.4M
 
 
 
 
 
Net Income196.2M264.8M253.1M248.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS104.6M104.8M105.1M105.6M
 
 
 
 
 
Shares To Calculate EPS Diluted116.2M116.5M115.8M115.1M
 
 
 
 
 
 
Earnings Per ShareEPS$1.69$2.27$2.19$2.16
 
 
 
 
 
EPS Diluted$1.69$2.27$2.19$2.16